Quantcast

Latest Adderall Stories

2014-05-12 08:31:08

DUBLIN and SAN DIEGO, May 12, 2014 /PRNewswire/ -- - Acquisition of Lumena Pharmaceuticals, a biopharmaceutical company with late stage rare disease pipeline assets - Adds to Shire's rare diseases portfolio and leverages this expertise, and is a perfect combination with Shire's already strong Gastrointestinal (GI) presence - Adds LUM001 in Phase 2 development for four rare and devastating hepatic diseases, two...

2014-04-07 23:26:22

New supplement by Nature Optimized aims to naturally heal ADHD and the addictive brain. Spanish Fork, UT (PRWEB) April 07, 2014 Filling a much-needed gap in the ADHD supplement market, Nature Optimized makes liquid supplements with a unique, proprietary blend of fats and amino acids plus brain-supporting vitamins and minerals that is safe for children as well as pregnant women. The first formula, Pure Clarity Calm, increases focus and motivation while calming the active mind. The second...

2014-03-26 10:53:36

Millions of children in the UK are potentially receiving penicillin prescriptions below the recommended dose for common infections, according to new research led jointly by researchers at King's College London, St George's, University of London and Imperial College London. The authors are calling for an urgent review of penicillin dosing guidelines for children - which at the time of study had not changed in over 50 years - after discovering wide variation in current prescribing practice....

2014-03-14 12:28:50

LEXINGTON, Massachusetts, March 14, 2014 /PRNewswire/ -- Shire Pharmaceuticals announced today the initiation of a voluntary recall in the United States of one batch, packaged into three lots, of VPRIV due to the presence of visible particulate matter, identified as stainless steel and barium sulfate. The particulate matter was found in a small number of vials in the three packaged lots of VPRIV. A Shire investigation identified the particulate matter root cause as the third...

2014-02-25 08:32:17

TORONTO, Feb. 25, 2014 /PRNewswire/ - Highland Therapeutics Inc. ("Highland"), an emerging pharmaceutical company, today announced that the Company's President and Chief Executive Officer, David Lickrish, will present at the 34(th) Annual Cowen and Company Health Care Conference at the Boston Marriott Copley Place in Boston, MA. Highland's presentation is scheduled for Monday, March 3, 2014 at 11:00am EST. A live webcast of the presentation can be accessed by visiting...

2014-02-14 08:26:37

LEXINGTON, Massachusetts, February 14, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG), the global specialty biopharmaceutical company, announced today that the US Food & Drug Administration (FDA) has approved the production of VPRIV(R) drug substance (velaglucerase alfa for injection) in Shire's manufacturing facility at 400 Shire Way, Lexington, Massachusetts, US. The facility was previously approved by the European Medicines Agency (EMA) for production of VPRIV...

2014-02-13 08:30:34

DUBLIN, February 13, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces that Graham Hetherington, Chief Financial Officer (CFO), has notified the Board of Directors of his decision to step down. The Board has agreed that Graham will step down from Shire's Board of Directors on March 1, 2014. Shire's Senior Vice President and Group Financial Controller, James Bowling, will be appointed as interim Shire CFO with effect from that date. Shire will start immediately...

2014-02-11 23:29:05

MedicationDiscountCard.com makes treating ADHD more affordable. San Antonio, TX (PRWEB) February 11, 2014 The Diagnostic and Statistical Manual (DSM5) says that about 5% of children in the United States have attention-deficit hyperactivity disorder, or ADHD. Boys are diagnosed more often than girls, and numbers vary by state, with some states reaching as high as 18% of children diagnosed with ADHD. When children aren't properly medicated, the extra care they require puts a huge...

2014-01-17 04:20:47

DUBLIN, January 17, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG), the global specialty biopharmaceutical company, today announced that it has entered into a definitive agreement pursuant to which it has sold its DERMAGRAFT assets to Organogenesis Inc. DERMAGRAFT is a living skin substitute indicated for use in the treatment of full-thickness diabetic foot ulcers and is approved for use in the US and Canada. Going forward Organogenesis will assume all financial and...

2014-01-14 12:26:31

DUBLIN, January 14, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) Dr. Flemming Ornskov, Chief Executive Officer of Shire, will address investors today, Tuesday, January 14, 2014, at the JP Morgan Healthcare Conference in San Francisco. In his address he will confirm that Shire finished 2013 strongly, having successfully performed a strategy shift and introduced greater operational discipline. Shire now expects to deliver Non GAAP EPS growth at the upper end of...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related